Leading Independent Hong Kong Law Firm

Proposed resolution under the Pneumoconiosis and Mesothelioma (Compensation) Ordinance (section 40 of Cap. 360)

Mar 19, 2025
Latest News LEGCO Proposed resolution under the Pneumoconiosis and Mesothelioma (Compensation) Ordinance (section 40 of Cap. 360)

On March 19, 2025, LegCo approved a resolution under the Pneumoconiosis and Mesothelioma (Compensation) Ordinance (section 40 of Cap. 360) to adjust compensation amounts based on wage and price movements, benefits under the CSSA Scheme, and operational experience.

This article was generated using SAMS, an AI technology by Timothy Loh LLP.

On March 19, 2025, LegCo approved a resolution under the Pneumoconiosis and Mesothelioma (Compensation) Ordinance (section 40 of Cap. 360) to adjust compensation amounts based on wage and price movements, benefits under the Comprehensive Social Security Assistance ("CSSA") Scheme, and operational experience. The resolution aims to ensure that injured employees, persons suffering from pneumoconiosis and mesothelioma, and persons with occupational deafness receive reasonable protection. The adjustments will come into effect on 17 April 2025.

The subsidiary legislation focuses on enhancing the compensation framework under the Pneumoconiosis and Mesothelioma (Compensation) Ordinance ("PMCO"). It aims to provide up-to-date and fair compensation by adjusting compensation amounts based on current wage and price indices, as well as benefits provided under the Comprehensive Social Security Assistance ("CSSA") Scheme. The legislation also takes into account operational experience to ensure that the adjustments reflect practical considerations and real-world scenarios, thereby promoting fairness and effectiveness in the compensation process.

View the full article:Source

We use cookies to enhance your experience of our websites and to enable you to register when necessary. By continuing to use this website, you agree to the use of these cookies. For more information and to learn how you can change your cookie settings, please see our Cookie Policy and our Privacy Notice.